Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Published in: Calcified Tissue International 1/2008

01-01-2008

Different Gene Expression Patterns in the Bone Tissue of Aging Postmenopausal Osteoporotic and Non-osteoporotic Women

Authors: Bernadett Balla, János P. Kósa, János Kiss, Adrienn Borsy, János Podani, István Takács, Áron Lazáry, Zsolt Nagy, Krisztián Bácsi, Gábor Speer, László Orosz, Péter Lakatos

Published in: Calcified Tissue International | Issue 1/2008

Login to get access

Abstract

Purpose

To identify genes that are differently expressed in osteoporotic and non-osteoporotic human bone and to describe the relationships between these genes using multivariate data analysis.

Methods

Seven bone tissue samples from postmenopausal osteoporotic patients and 10 bone tissue samples from postmenopausal non-osteoporotic women were examined in our study. Messenger RNA was prepared from each sample and reverse transcribed to cDNA. The expression differences of 87 selected genes were analyzed in a Taqman probe-based quantitative real-time RT-PCR system.

Results

A Mann-Whitney U-test indicated significant differences in the expression of nine genes (p ≤ 0.05). Seven of these nine genes–ALPL, COL1A1, MMP2, MMP13, MMP9, PDGFA, NFKB1—were significantly downregulated in the bone tissue of osteoporotic women, while CD36 and TWIST2 were significantly upregulated in osteoporotic patients. Principal components analysis was used to evaluate data structure and the relationship between osteoporotic and non-osteoporotic phenotypes based on the multiple mRNA expression profiles of 78 genes. Canonical variates analysis demonstrated further that osteoporotic and non-osteoporotic tissues can be distinguished by expression analysis of genes coding growth factors/non-collagen matrix molecules, and genes belonging to the canonical TGFB pathway.

Conclusion

Significant differences observed in gene expression profiles of osteoporotic and non-osteoporotic human bone tissues provide further insight into the pathogenesis of this disease. Characterization of the differences between osteoporotic and non-osteoporotic bones by expression profiling will contribute to the development of diagnostic tools in the future.
Literature
1.
Prentice A (2001) The relative contribution of diet and genotype to bone development. Proc Nutr Soc 60:45–52PubMedCrossRef
2.
Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3–11PubMedCrossRef
3.
4.
Zajickova K, Zofkova I (2003) Osteoporosis: Genetic analysis of multifactorial disease. Endocr Regul 37:31–44PubMed
5.
Rizzoli R, Bonjour JP, Ferrari SL (2001) Osteoporosis, genetics and hormones. J Mol Endocrinol 26:79–94PubMedCrossRef
6.
Dvornyk V, Recker RR, Deng HW (2003) Gene expression studies of osteoporosis: Implications for microarray research. Osteoporos Int 14:451–461PubMedCrossRef
7.
Ralston SH (1994) Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9:883–890PubMedCrossRef
8.
Abrahamsen B, Shalhoub V, Larson EK, Eriksen EF, Beck-Nielsen H, Marks SC Jr (2000) Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women. Bone 26:137–145PubMedCrossRef
9.
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502PubMedCrossRef
10.
Jolliffe I (1986) Principal component analysis. Springer, Berlin Heidelberg New York
11.
Podani J (2000) Introduction to the exploration of multivariate biological data. Backhuys, Leiden
12.
Raychaudhuri S, Stuart JM, Altman RB (2000) Principal components analysis to summarize microarray experiments: Application to sporulation time series. Pac Symp Biocomput [2000]:455–466
13.
Yeung KY, Ruzzo WL (2001) Principal component analysis for clustering gene expression data. Bioinformatics 17:763–774PubMedCrossRef
14.
Dai JJ, Lieu L, Rocke D (2006) Dimension reduction for classification with gene expression microarray data. Stat Appl Genet Mol Biol 5:article 6
15.
Cattell R (1966) The scree test for the number of factors. Multivar Behav Res 1:140–161
16.
Podani J (2001) SYN-TAX 2000: User’s manual. Scientia, Budapest
17.
Kawabata M, Imamura T, Miyazono K (1998) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9:49–61PubMedCrossRef
18.
Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51–65PubMedCrossRef
19.
20.
21.
Christenson RH (1997) Biochemical markers of bone metabolism: An overview. Clin Biochem 30:573–593PubMedCrossRef
22.
Vega D, Maalouf NM, Sakhaee K (2007) The role of RANK/RANKL/OPG: Clinical implications. J Clin Endocrinol Metab 92(12):4514–4521PubMedCrossRef
23.
Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221–233PubMedCrossRef
24.
Torricelli P, Fini M, Giavaresi G, Giardino R (2002) Human osteoblast cultures from osteoporotic and healthy bone: Biochemical markers and cytokine expression in basal conditions and in response to 1,25(OH)2D3. Artif Cells Blood Substit Immobil Biotechnol 30:219–227PubMedCrossRef
25.
Mueller SM, Glowacki J (2001) Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 82:583–590PubMedCrossRef
26.
Rodriguez JP, Montecinos L, Rios S, Reyes P, Martinez J (2000) Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem 79:557–565PubMedCrossRef
27.
Abdallah BM, Haack-Sorensen M, Fink T, Kassem M (2006) Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39:181–188PubMedCrossRef
28.
Cao J, Venton L, Sakata T, Halloran BP (2003) Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res 18:270–277PubMedCrossRef
29.
Carron JA, Wagstaff SC, Gallagher JA, Bowler WB (2000) A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro. Biochem Biophys Res Commun 270:1124–1127PubMedCrossRef
30.
Calvo D, Gomez-Coronado D, Suarez Y, Lasuncion MA, Vega MA (1998) Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 39:777–788PubMed
31.
Kawaguchi H, Akune T, Yamaguchi M, Ohba S, Ogata N, Chung UI, Kubota N, Terauchi Y, Kadowaki T, Nakamura K (2005) Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells. J Bone Miner Metab 23:275–279PubMedCrossRef
32.
Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B (2004) Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 3:379–389PubMedCrossRef
33.
Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J (1999) Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21:76–83PubMedCrossRef
34.
Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93:229–240PubMedCrossRef
35.
Tamura M, Noda M (1999) Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells. J Cell Biochem 72:167–176PubMedCrossRef
36.
Gong XQ, Li L (2002) Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. J Biol Chem 277:12310–12317PubMedCrossRef
37.
Lee MS, Lowe G, Flanagan S, Kuchler K, Glackin CA (2000) Human Dermo-1 has attributes similar to twist in early bone development. Bone 27:591–602PubMedCrossRef
38.
Schroeder TM, Westendorf JJ (2005) Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res 20:2254–2263PubMedCrossRef
39.
Leeman MF, Curran S, Murray GI (2002) The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 37:149–166PubMedCrossRef
40.
Fridman R, Toth M, Pena D, Mobashery S (1995) Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548–2555PubMed
41.
Knauper V, Smith B, Lopez-Otin C, Murphy G (1997) Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem/FEBS 248:369–373CrossRef
42.
Hatori K, Sasano Y, Takahashi I, Kamakura S, Kagayama M, Sasaki K (2004) Osteoblasts and osteocytes express MMP2 and -8 and TIMP1, -2, and -3 along with extracellular matrix molecules during appositional bone formation. Anat Rec A 277:262–271CrossRef
43.
Filanti C, Dickson GR, Di Martino D, Ulivi V, Sanguineti C, Romano P, Palermo C, Manduca P (2000) The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. J Bone Miner Res 15:2154–2168PubMedCrossRef
44.
Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879–889PubMedCrossRef
45.
Rydziel S, Shaikh S, Canalis E (1994) Platelet-derived growth factor-AA and -BB (PDGF-AA and -BB) enhance the synthesis of PDGF-AA in bone cell cultures. Endocrinology 134:2541–2546PubMedCrossRef
46.
Hock JM, Canalis E (1994) Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts. Endocrinology 134:1423–1428PubMedCrossRef
47.
Fiedler J, Etzel N, Brenner RE (2004) To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93:990–998PubMedCrossRef
48.
Tanaka H, Wakisaka A, Ogasa H, Kawai S, Liang CT (2002) Effect of IGF-I and PDGF administered in vivo on the expression of osteoblast-related genes in old rats. J Endocrinol 174:63–70PubMedCrossRef
49.
Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17–25PubMedCrossRef
50.
Park H, Jung YK, Park OJ, Lee YJ, Choi JY, Choi Y (2005) Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J Immunol 175:7193–201PubMed
51.
Ozeki N, Mogi M, Nakamura H, Togari A (2002) Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells. Arch Oral Biol 47:511–517PubMedCrossRef
52.
Atkins GJ, Bouralexis S, Evdokiou A, Hay S, Labrinidis A, Zannettino AC, Haynes DR, Findlay DM (2002) Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone 31:448–56PubMedCrossRef
53.
Roux S, Lambert-Comeau P, Saint-Pierre C, Lepine M, Sawan B, Parent JL (2005) Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis. Biochem Biophys Res Commun 333:42–50PubMedCrossRef
Metadata
Title
Different Gene Expression Patterns in the Bone Tissue of Aging Postmenopausal Osteoporotic and Non-osteoporotic Women
Authors
Bernadett Balla
János P. Kósa
János Kiss
Adrienn Borsy
János Podani
István Takács
Áron Lazáry
Zsolt Nagy
Krisztián Bácsi
Gábor Speer
László Orosz
Péter Lakatos
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 1/2008
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-007-9092-3

Other articles of this Issue 1/2008

Calcified Tissue International 1/2008 Go to the issue

OriginalPaper

Association of Left Ventricular Function with Bone Mineral Density in Older Women: A Population-Based Study

OriginalPaper

The Effects of Bone Remodeling Inhibition by Alendronate on Three-Dimensional Microarchitecture of Subchondral Bone Tissues in Guinea Pig Primary Osteoarthrosis

OriginalPaper

Anxiolytics and Sedatives and Risk of Fractures: Effects of Half-life

OriginalPaper

Cell Surface Expression of Stem Cell Antigen-1 (Sca-1) Distinguishes Osteo-, Chondro-, and Adipoprogenitors in Fetal Mouse Calvaria

OriginalPaper

Phenotypic Characteristics of Bone in Carbonic Anhydrase II-Deficient Mice

OriginalPaper

Identification of a Ca2+-Sensing Receptor in Rat Trigeminal Ganglia, Sensory Axons, and Tooth Dental Pulp
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits